Association between estrogen receptor status and Oncotype Dx breast recurrence score.

被引：2
|
作者：
Khan, Noman Ahmed Jang [1 ]
Abdallah, Mahmoud [1 ]
Gress, Todd W. [1 ]
Alsharedi, Mohamed Farouq [1 ]
机构：
[1] Marshall Univ, Joan C Edwards Sch Med, Huntington, WV USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e12519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12519
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Correlation of oncotype DX recurrence score with histologic grading and estrogen receptor positivity
    Bhargava, Rohit
    Dabbs, David
    Brufsky, Adam
    Beriwal, Sushil
    MODERN PATHOLOGY, 2006, 19 : 8 - 9
  • [2] Correlative Analysis of miRNA Expression and Oncotype Dx Recurrence Score in Estrogen Receptor Positive Breast Carcinomas
    Emmadi, Rajyasree
    Canestrari, Emanuele
    Arbieva, Zarema H.
    Mu, Wenbo
    Dai, Yang
    Frasor, Jonna
    Wiley, Elizabeth
    PLOS ONE, 2015, 10 (12):
  • [3] Comparison between the Nottingham Prognostic Index and Oncotype Dx Recurrence Score in Predicting Outcome in Estrogen Receptor Positive Breast Cancer
    Kerin, Eoin Patrick
    Davey, Matthew G.
    Malone, Carmel
    Barry, Michael K.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 236 (05) : S5 - S6
  • [4] Is there a role for the oncotype DX breast recurrence score genomic assay in estrogen receptor-low positive breast cancer?
    Giordano, Julia
    McGrath, Monica
    Harrison, Beth
    Kantor, Olga
    Vora, Halley
    Burstein, Harold J.
    Tolaney, Sara M.
    King, Tari A.
    Mittendorf, Elizabeth A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [5] Association of race, reproductive factors, and lifestyle factors with tumor subtype defined by Oncotype DX recurrence score.
    Benefield, Halei
    Reeder-Hayes, Katherine Elizabeth
    Wheeler, Stephanie B.
    Carey, Lisa A.
    Olshan, Andrew F.
    Troester, Melissa
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Can Conventional Histopathologic Prognostic Parameters of Invasive Breast Carcinoma Predict the Oncotype DX™ Recurrence Score.
    Bose, S.
    Mannan, A. A. S. R.
    Rathgeh, T.
    MODERN PATHOLOGY, 2011, 24 : 29A - 29A
  • [7] The Effect of Oncotype Dx® Recurrence Score on Treatment Recommendations for Patients with Early Stage Estrogen Receptor Positive Breast Cancer
    Acs, G.
    Esposito, N.
    Kiluk, J.
    Laronga, C.
    Lee, M. C.
    Loftus, L.
    Soliman, H.
    Boughey, J. C.
    Reynolds, C.
    Acs, P.
    Gordan, L.
    CANCER RESEARCH, 2009, 69 (24) : 726S - 726S
  • [8] Comparison of Magee and Oncotype DX Recurrence Scores in estrogen receptor positive breast cancers
    Walts, Ann E.
    Mirocha, James M.
    Bose, Shikha
    BREAST JOURNAL, 2018, 24 (06): : 951 - 956
  • [9] Menopausal status does not predict Oncotype DX recurrence score
    Carr, Danielle N.
    Vera, Nora
    Sun, Weihong
    Lee, Marie Catherine
    Hoover, Susan
    Fulp, William
    Acs, Geza
    Laronga, Christine
    JOURNAL OF SURGICAL RESEARCH, 2015, 198 (01) : 27 - 33
  • [10] Association of Insulin Resistance and Higher Oncotype DX™ Recurrence Score
    Gordon, Nicole T.
    Alberty-Oller, Jaime J.
    Fei, Kezhen
    Greco, Giampaolo
    Gallagher, Emily J.
    LeRoith, Derek
    Feldman, Sheldon M.
    Killilea, Bridgid
    Boolbol, Susan K.
    Choi, Lydia
    Friedman, Neil
    Pilewskie, Melissa
    Port, Elisa
    Tiersten, Amy
    Bickell, Nina A.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 5941 - 5947
12345